- $390.63m
- $521.43m
- $822.31m
Brief: Orthofix And Seaspine Announce John Bostjancic To Serve As CFO For Combined Company Post Closing
Orthofix Medical Inc reports results for the quarter ended in September - Earnings Summary
Brief: Orthofix Reports Third Quarter 2022 Results
Orthofix Medical Inc expected to post earnings of 12cents a share - Earnings Preview
Brief: Orthofix Announces First Patient Implants With Legacy Demineralized Bone Matrix For Spine, Pelvic And Extremities Procedures
Brief: Orthofix Announces Preliminary Third Quarter And Year-To-Date 2022 Net Sales Results
SeaSpine Holdings up on merger deal with Orthofix
Brief: Orthofix And Seaspine To Merge To Create Leading Global Spine And Orthopedics Co
Brief: Orthofix Reports Data At North American Spine Society Annual Meeting
Brief: Orthofix Reports Second Quarter 2022 Results
Brief: Orthofix Medical And CGBio Announce Strategic Partnership Agreement For Novosis rhBMP-2 Bone Graft Solutions
Brief: Orthofix Announces First Clinical Use Of Virtuos Lyograft
Brief: Orthofix Reports First Quarter 2022 Results
Orthofix Medical Inc expected to post earnings of 9 cents a share - Earnings Preview
Brief: Orthofix Medical Announces Renewal, Expansion Of Partnership Agreement With MTF Biologics
Orthofix Medical Inc expected to post earnings of 9 cents a share - Earnings Preview
Brief: Orthofix Announces FDA Clearance, First Patient Cases With Truelok Evo Ring Fixation System
Orthofix Medical Inc reports results for the quarter ended in December - Earnings Summary
Brief: Orthofix Reports Fourth Quarter And Fiscal Year 2021 Results